Botamedi

South Korea
Gangneung, Gangwon-do, South Korea, 06158

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
1
Total equity funding
$657.8M
Last funding
Series B / $657.8M / 2022-03-23
Last equity funding
Series B / $657.8M
Investors
1
Lead investors
1

Founders and investors

Lead investors

DWS Group

Investors

DWS Group